The impact of intratumoral heterogeneity on prognostic biomarkers in localized prostate cancer.

被引：1
|
作者：
Brastianos, Harry
Murgic, Jure
Salcedo, Adriana
Chua, Melvin Lee Kiang
Meng, Alice
Fraser, Michael
Brundage, Michael Donald
Fleshner, Neil Eric
van der Kwast, Theodorus
Bristow, Robert G.
Boutros, Paul Christopher
Berlin, Alejandro
机构：
[1] Queens Univ, Kingston, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Ontario Inst Canc Res, Toronto, ON, Canada
[4] Natl Canc Ctr, Singapore, Singapore
[5] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, STTARR Innovat Ctr,Radiat Med Program, Toronto, ON, Canada
[6] Queens Univ, Canc Res Inst, Div Canc Care & Epidemiol, Kingston, ON, Canada
[7] Univ Hlth Network, Div Urol, Dept Surg, Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada
[9] Manchester Canc Res Ctr, Manchester, Lancs, England
[10] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 07期
关键词：
D O I：
10.1200/JCO.2019.37.7_suppl.46
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
46
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Brachytherapy in the curative treatment of localized prostate cancer.
    Flam, T
    Chauveinc, L
    Servois, V
    Rosenwald, JC
    Cosset, JM
    Thiounn, N
    Debré, B
    PROGRES EN UROLOGIE, 2000, 10 (01): : 3 - 13
  • [32] Localized prostate cancer. What to say to the patient?
    Coloby, P.
    ANNALES D UROLOGIE, 2006, 40 : S18 - S23
  • [33] Prediction of tumor heterogeneity in localized prostate cancer
    Huland, H
    Graefen, M
    Haese, A
    Hammerer, PG
    Palisaar, J
    Pichlmeier, U
    Henke, RP
    Erbersdobler, A
    Huland, E
    Lilja, H
    UROLOGIC CLINICS OF NORTH AMERICA, 2002, 29 (01) : 213 - +
  • [34] Focal intratumoral heterogeneity for telomerase activity in human prostate cancer
    Wullich, B
    Rohde, V
    Oehlenschläger, B
    Bonkhoff, H
    Ketter, R
    Zwergel, T
    Sattler, HP
    JOURNAL OF UROLOGY, 1999, 161 (06): : 1997 - 2001
  • [35] Delineation of prognostic biomarkers in prostate cancer
    Saravana M. Dhanasekaran
    Terrence R. Barrette
    Debashis Ghosh
    Rajal Shah
    Sooryanarayana Varambally
    Kotoku Kurachi
    Kenneth J. Pienta
    Mark A. Rubin
    Arul M. Chinnaiyan
    Nature, 2001, 412 : 822 - 826
  • [36] Delineation of prognostic biomarkers in prostate cancer
    Dhanasekaran, SM
    Barrette, TR
    Ghosh, D
    Shah, R
    Varambally, S
    Kurachi, K
    Pienta, KJ
    Rubin, MA
    Chinnaiyan, AM
    NATURE, 2001, 412 (6849) : 822 - 826
  • [37] Prognostic and predictive biomarkers in prostate cancer
    Kontos, Christos K.
    Adamopoulos, Panagiotis G.
    Scorilas, Andreas
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2015, 15 (12) : 1567 - 1576
  • [38] Diagnostic and prognostic biomarkers in prostate cancer
    Mehilli, B.
    Anila, R.
    Topi, F.
    Cabiri, Z.
    CLINICA CHIMICA ACTA, 2024, 558 : 22 - 22
  • [39] Prognostic microRNAs as biomarkers for prostate cancer
    Palanisamy, Hema
    Manoharan, Jeevitha Priya
    Vidyalakshmi, Subramanian
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (01) : 297 - 303
  • [40] Identification of prognostic biomarkers for prostate cancer
    Kosari, Farhad
    Munz, Jan Marie A.
    Savci-Heijink, C. Dilara
    Spiro, Craig
    Klee, Eric W.
    Kube, Dagmar Marie
    Tillmans, Lori
    Slezak, Jeff
    Karnes, R. Jeffrey
    Cheville, John C.
    Vasmatzis, George
    CLINICAL CANCER RESEARCH, 2008, 14 (06) : 1734 - 1743
12345